DEXCOM, INC. Line of Credit, Current
DEXCOM, INC. (DXCM) had Line of Credit, Current of $0 as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2019-11-06
- 2019-09-30: Line of Credit, Current $0.00.
- 2019-06-30: Line of Credit, Current $0.00.
- 2019-03-31: Line of Credit, Current $0.00.
- 2018-09-30: Line of Credit, Current $0.00.
| Period end | Line of Credit, Current |
|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-31 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 |
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-01 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-01 |
| 2017-03-31 | $75.00M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $0.00 10-Q · filed 2017-05-02 |
| 2011-12-31 | $0.00 10-K · filed 2012-02-23 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-02 |
| 2011-06-30 | $75.00K 10-Q · filed 2011-08-03 |
| 2010-12-31 | $525.00K 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |